List of Excipients in Branded Drug RABEPRAZOLE SODIUM

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Sarras Health LLC	RABEPRAZOLE SODIUM DELAYED-RELEASE	rabeprazole sodium	72834-210	CARRAGEENAN
Sarras Health LLC	RABEPRAZOLE SODIUM DELAYED-RELEASE	rabeprazole sodium	72834-210	DIACETYLATED MONOGLYCERIDES
Sarras Health LLC	RABEPRAZOLE SODIUM DELAYED-RELEASE	rabeprazole sodium	72834-210	ETHYLCELLULOSES
Sarras Health LLC	RABEPRAZOLE SODIUM DELAYED-RELEASE	rabeprazole sodium	72834-210	FD&C YELLOW NO. 6
Sarras Health LLC	RABEPRAZOLE SODIUM DELAYED-RELEASE	rabeprazole sodium	72834-210	HYDROXYPROPYL CELLULOSE

Generic Drugs Containing RABEPRAZOLE SODIUM

Company	Ingredient	NDC	Excipient
Teva Pharmaceuticals USA Inc	rabeprazole sodium	0093-0064	CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc	rabeprazole sodium	0093-0064	D&C YELLOW NO. 10 ALUMINUM LAKE
Teva Pharmaceuticals USA Inc	rabeprazole sodium	0093-0064	FD&C YELLOW NO. 6
Teva Pharmaceuticals USA Inc	rabeprazole sodium	0093-0064	FERROSOFERRIC OXIDE
Teva Pharmaceuticals USA Inc	rabeprazole sodium	0093-0064	HYDROXYPROPYL CELLULOSE

What are the Most Frequently-Used Excipients in RABEPRAZOLE SODIUM?

# Of NDCs	Excipient
14	ALCOHOL
1	ALUMINUM OXIDE
29	AMMONIA
14	BUTYL ALCOHOL
20	CARNAUBA WAX

Excipient Strategy and Commercial Opportunities for Rabeprazole Sodium

Last updated: March 2, 2026

What are the critical excipient considerations for Rabeprazole Sodium formulations?

Rabeprazole sodium, a proton pump inhibitor used for GERD and ulcers, relies heavily on specific excipients to enhance stability, bioavailability, and patient compliance. Stabilizers such as sodium bicarbonate or substitutes protect the drug from gastric acid degradation, while binders, fillers, and lubricants facilitate manufacturing. The choice of excipients impacts drug efficacy, shelf life, and regulatory approval processes.

Key excipient functions include:

• Protection from gastric acid: Sodium bicarbonate and other buffering agents prevent premature degradation.
• Film formation and coating: Hydroxypropyl methylcellulose (HPMC) and ethylcellulose suppress gastric acid exposure during transit.
• Enhancement of solubility: Use of cyclodextrins or other solubilizers may be considered for improved absorption.
• Manufacturing process aids: Povidone, magnesium stearate, and microcrystalline cellulose support compressibility and flowability.

Excipient regulatory landscape

Regulatory bodies (FDA, EMA) require detailed documentation on excipients' safety, compatibility, and source, especially given the chronic use of Rabeprazole sodium.

How do excipient choices influence commercial opportunities?

Excipient strategy directly affects formulation stability, shelf life, patient acceptability, and development costs. These factors determine a drug’s market competitiveness and pricing.

Opportunities through innovative excipients

• Enhanced stability: Reformulation with newer stabilizers could extend shelf life, especially in tropical climates.
• Improved bioavailability: Using solubilizers or permeability enhancers may allow for lower doses, reducing manufacturing costs.
• Patient-centric formulations: Developing pediatric or GERD-specific formulations (e.g., orodispersible tablets, suspensions) can capture niche markets.
• Regulatory and patent advantages: Novel excipient combinations enable the filing of innovative patents, delaying generic entry.

Market leader strategies

Companies leverage excipient innovations to differentiate products:

Company	Strategy	Market Outcome
Takeda	Patented new coating techniques	Extended patent exclusivity, premium pricing
AstraZeneca	Incorporation of bioavailability enhancers	Broader patent scope, improved absorption
Teva	Cost-effective excipients for generics	Competitive pricing, increased market share

Challenges and risks

• Compatibility issues: Excipients may interact negatively with Rabeprazole sodium, causing degradation.
• Regulatory delays: Novel excipients require extensive safety data.
• Scale-up complexity: Manufacturing changes may increase costs or introduce variability.

What are the commercial and strategic implications?

Developing unique or optimized excipient formulations can enable brand differentiation and new indications. Strategic partnerships with excipient specialists could facilitate access to cutting-edge stabilizers or delivery technologies. Economies of scale in sourcing excipients may reduce costs, benefiting margins.

Summary table of key excipient considerations

Aspect	Details	Business Implication
Stability	Use of buffering agents for gastric protection	Longer shelf life, market expansion in diverse climates
Patient compliance	Developing dispersible or liquid formulations	Access to pediatric and geriatric markets
Cost efficiency	Selecting cost-effective excipients	Increased profit margins, price competitiveness
Patentability	Novel excipient combinations	Market exclusivity, licensing opportunities

Key Takeaways

• Excipient selection for Rabeprazole sodium impacts stability, absorption, and patient acceptance.
• Innovations in excipients can extend patents and support differentiated formulations.
• Cost-effective excipient sourcing and novel delivery technologies present commercial opportunities.
• Regulatory considerations are paramount; safety data and compatibility are critical.
• Developing niche formulations suited for specific patient populations can capture new markets.

FAQs

1. Which excipients are most common in Rabeprazole sodium formulations?
Buffering agents (sodium bicarbonate), film coatings (HPMC), binders (povidone), and lubricants (magnesium stearate).

2. How can excipient innovation extend patent life?
By creating formulations with novel excipient combinations or delivery methods, companies can secure additional patent protection.

3. Are there regulatory hurdles for new excipients?
Yes. New excipients must meet safety and compatibility standards, often requiring extensive testing and approval.

4. What are the advantages of using bioavailability enhancers in Rabeprazole sodium?
They increase drug absorption, allowing lower doses, reducing side effects, and potentially lowering production costs.

5. How does excipient selection impact global distribution?
Excipients that improve stability and shelf life enable broader distribution, especially in regions with challenging climates.

---

References

[1] U.S. Food and Drug Administration. (2021). Guidance for Industry: Packaging, Storage, and Handling.
[2] European Medicines Agency. (2018). Guideline on Excipients in Large-Size Containers.
[3] Shinde, S., et al. (2020). Excipient selection for stability improvement of proton pump inhibitors. Journal of Pharmaceutical Sciences, 109(3), 814-824.